Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
Triage LVO
Triage LVO
Brainomix
Brainomix Triage LVO is a notification-only, parallel workflow tool for use by hospital networks and trained clinicians to identify and communicate images of specific patients to a specialist, independent of standard of care workflow. Brainomix Triage LVO uses an artificial intelligence algorithm to analyze images for findings suggestive of a prespecified clinical condition and to notify an appropriate medical specialist of these findings in parallel to standard of care image interpretation. Identification of suspected findings is not for diagnostic use beyond notification. Specifically, the device analyzes CT angiogram images of the brain acquired in the acute setting, and sends notifications to a neurovascular specialist that a suspected large vessel occlusion (LVO) has been identified and recommends review of those images. Images can be previewed through a mobile application or via email. Brainomix Triage LVO is intended to analyze terminal ICA and MCA-M1 vessels for LVOs.
Information source:
Vendor
Last updated:
Feb. 18, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
Triage LVO
Company
Brainomix
Subspeciality
Neuro
Modality
CT
Disease targeted
Stroke
Key-features
Notification of large vessel occlusions (MCA-M1 and ICA)
Suggested use
Technical Specifications
Data characteristics
Population
Adult patients with suspicion of stroke
Input
CTA
Input format
DICOM
Output
Notifications via a web user interface or mobile application. Compressed preview images meant for informational purposes only.
Output format
Technology
Integration
Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
Regulatory
Certification
CE
No or not yet,
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
09-2023
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers